Autoantibodies against mutated citrullinated Vimentin (anti-MCV) in the elderly population

被引:0
|
作者
Brickmann, K. P.
Yazdani-Biuki, B. J.
Graninger, M.
Brezinschek, R. I.
Stoiser, E.
Graninger, W. B.
Brezinschek, H. P.
机构
[1] Div Rheumatol, Graz, Austria
[2] Univ Hosp, Div Hematol, Graz, Austria
[3] Geriatr Hlth Ctr, Graz, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:580 / 581
页数:2
相关论文
共 50 条
  • [41] Differentiation of Rheumatoid Arthritis From HCV Infection: Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide or Anti-Mutated Citrullinated Vimentin?
    Kaptanoglu, Ece
    Nadir, Isilay
    Bakici, Zahir
    Hayta, Emrullah
    Turkmen, Mehmet
    Sezer, Hafize
    Hizmetli, Sami
    Elden, Hasan
    TURKISH JOURNAL OF RHEUMATOLOGY, 2010, 25 (01) : 19 - 23
  • [42] THE DIAGNOSTIC UTILITY OF ANTI-MUTATED CITRULLINATED VIMENTIN ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES AND RHEUMATOID FACTOR IN RHEUMATOID ARTHRITIS
    Eldin, A. Radr
    Mobasher, S. A.
    Hegazy, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 898 - 898
  • [43] Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
    Al-Shukaili, Ahmed
    Al-Ghafri, Saif
    Al-Marhoobi, Safia
    Alkaabi, Juma
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
  • [44] Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features
    Alessandri, Cristiano
    Agmon-Levin, Nancy
    Conti, Fabrizio
    Perricone, Carlo
    Ortona, Elena
    Pendolino, Monica
    Capozzi, Antonella
    Delunardo, Federica
    Mancini, Riccardo
    Truglia, Simona
    Spinelli, Francesca Romana
    Ceccarelli, Fulvia
    Sorice, Maurizio
    Shoenfeld, Yehuda
    Valesini, Guido
    IMMUNOLOGIC RESEARCH, 2017, 65 (02) : 524 - 531
  • [45] Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features
    Cristiano Alessandri
    Nancy Agmon-Levin
    Fabrizio Conti
    Carlo Perricone
    Elena Ortona
    Monica Pendolino
    Antonella Capozzi
    Federica Delunardo
    Riccardo Mancini
    Simona Truglia
    Francesca Romana Spinelli
    Fulvia Ceccarelli
    Maurizio Sorice
    Yehuda Shoenfeld
    Guido Valesini
    Immunologic Research, 2017, 65 : 524 - 531
  • [46] Anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis patients: Relation to disease activity and manifestations
    El Shazly, Reem Ismail
    Hussein, Somaya Anwar
    Raslan, Hala Zaki
    Elgogary, Amira Ahmed
    EGYPTIAN RHEUMATOLOGIST, 2014, 36 (02): : 65 - 70
  • [47] Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis
    Ishigooka, Nozomi
    Fujii, Takao
    Abe, Hiroyasu
    Murakami, Kosaku
    Nakashima, Ran
    Hashimoto, Motomu
    Yoshifuji, Hajime
    Tanaka, Masao
    Ito, Hiromu
    Ohmura, Koichiro
    Morita, Satoshi
    Mimori, Tsuneyo
    MODERN RHEUMATOLOGY, 2020, 30 (03) : 450 - 457
  • [48] The Anti-mutated Citrullinated Vimentin Response Classifies Patients with Rheumatoid Arthritis into Broad and Narrow Responders
    Engelmann, Robby
    Brandt, Jan
    Eggert, Martin
    Karberg, Kirsten
    Krause, Andreas
    Neeck, Gunther
    Mueller-Hilke, Brigitte
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (12) : 2670 - 2674
  • [49] Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort
    Degboe, Yannick
    Constantin, Arnaud
    Nigon, Delphine
    Tobon, Gabriel
    Cornillet, Martin
    Schaeverbeke, Thierry
    Chiocchia, Gilles
    Nicaise-Roland, Pascale
    Nogueira, Leonor
    Serre, Guy
    Cantagrel, Alain
    Ruyssen-Witrand, Adeline
    RMD OPEN, 2015, 1 (01):
  • [50] DIAGNOSTIC VALUE OF ANTI MUTATED CITRULLINATED VIMENTIN IN COMPARISON TO ANTI-CYCLIC CITRULLINATED PEPTIDE AND ANTI-VIRAL CITRULLINATED PEPTIDE 2 ANTIBODIES IN RHEUMATOID ARTHRITIS: A MULTICENTRIC STUDY BY FIRMA GROUP
    Bartoloni, E.
    Alunno, A.
    Bistoni, O.
    Bizzaro, N.
    Morozzi, G.
    Doria, A.
    Mathieu, A.
    Lotzniker, M.
    Allegri, F.
    Riccieri, V.
    Alpini, C.
    Gabrielli, A.
    Tampoia, M.
    Gerli, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 607 - 607